Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Shapiro

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
BMJ (Clinical Research Ed.)|November 18, 2024
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trialKatrin Schaudig, Xuegong Wang, Céline Bouchard, et al.
Archives of Osteoporosis|May 5, 2022
A retrospective observational study of osteoporosis management after a fragility fracture in primary careAlan Bell, David L Kendler, Aliya A Khan, et al.
Maturitas|December 19, 2025
Fezolinetant compared with elinzanetant for the treatment of vasomotor symptoms associated with menopause: A matching-adjusted indirect comparisonPetra Stute, Marla Shapiro C M, Antonia Morga, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2023
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCTKimball A Johnson, Nancy Martin, Rossella E Nappi, et al.
Canadian Family Physician Medecin De Famille Canadien|September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
Menopause (New York, N.Y.)|June 13, 2019
An individualized approach to the management of vaginal atrophy in Latin AmericaSantiago Palacios, Rossella E Nappi, Marla Shapiro, et al.
Menopause (New York, N.Y.)|May 16, 2018
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual HealthStephanie S Faubion, Lisa C Larkin, Cynthia A Stuenkel, et al.
Menopause (New York, N.Y.)|October 15, 2014
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause SocietyJoAnn E Manson, Jeffrey M Ames, Marla Shapiro, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
BMJ (Clinical Research Ed.)|November 18, 2024
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trialKatrin Schaudig, Xuegong Wang, Céline Bouchard, et al.
Archives of Osteoporosis|May 5, 2022
A retrospective observational study of osteoporosis management after a fragility fracture in primary careAlan Bell, David L Kendler, Aliya A Khan, et al.
Maturitas|December 19, 2025
Fezolinetant compared with elinzanetant for the treatment of vasomotor symptoms associated with menopause: A matching-adjusted indirect comparisonPetra Stute, Marla Shapiro C M, Antonia Morga, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2023
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCTKimball A Johnson, Nancy Martin, Rossella E Nappi, et al.
Canadian Family Physician Medecin De Famille Canadien|September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
Menopause (New York, N.Y.)|June 13, 2019
An individualized approach to the management of vaginal atrophy in Latin AmericaSantiago Palacios, Rossella E Nappi, Marla Shapiro, et al.
Menopause (New York, N.Y.)|May 16, 2018
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual HealthStephanie S Faubion, Lisa C Larkin, Cynthia A Stuenkel, et al.
Menopause (New York, N.Y.)|October 15, 2014
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause SocietyJoAnn E Manson, Jeffrey M Ames, Marla Shapiro, et al.
Pageof 3